VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+2.16%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$996M
AUM Growth
+$996M
(-31%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-25.87%
Top 10 Holdings %
Top 10 Hldgs %
67.37%
Holding
55
New
1
Increased
2
Reduced
8
Closed
6
Top Buys
| 1 |
Zai Lab
ZLAB
|
$3.12M |
| 2 |
Rezolute
RZLT
|
$1.58M |
| 3 |
GTH
Genetron Holdings Limited ADS
GTH
|
$1.21M |
Top Sells
| 1 |
NFH
New Frontier Health Corporation Ordinary Shares
NFH
|
$171M |
| 2 |
Ascendis Pharma
ASND
|
$27.6M |
| 3 |
Harmony Biosciences
HRMY
|
$23.2M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11.5M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$9.85M |
Sector Composition
| 1 | Healthcare | 97.84% |
| 2 | Materials | 2.16% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Harmony Biosciences
HRMY
$2.12B
| $200M | 20.05% | 4,093,785 -476,363 | -10% | -$23.2M |
|
|
SRRA
2
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $183M | 18.38% | 3,329,509 -2 | -0% | -$110 |
|
3
Instil Bio
TIL
$182M
| $57.7M | 5.79% | 12,486,787 | – | – |
|
|
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $50.4M | 5.06% | 5,238,634 -1,193,306 | -19% | -$11.5M |
|
|
SVA
5
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 3.83% | 5,900,000 | – | – |
|
6
ALX Oncology
ALXO
$62.7M
| $34.1M | 3.43% | 4,220,048 | – | – |
|
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $33.8M | 3.39% | 2,312,368 -674,963 | -23% | -$9.85M |
|
|
IMPL
8
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $26.9M | 2.7% | 2,884,789 | – | – |
|
9
Geron
GERN
$893M
| $23.6M | 2.37% | 15,238,095 | – | – |
|
10
Ventyx Biosciences
VTYX
$171M
| $23.5M | 2.36% | 1,921,726 | – | – |
|
|
AMRS
11
DELISTED
Amyris Inc.
AMRS
| $21.5M | 2.16% | 11,642,195 | – | – |
|
12
Cogent Biosciences
COGT
$1.69B
| $17.3M | 1.74% | 1,920,941 | – | – |
|
|
KDNY
13
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.3M | 1.53% | 872,151 | – | – |
|
14
KalVista Pharmaceuticals
KALV
$678M
| $15.1M | 1.52% | 1,533,559 | – | – |
|
15
Celldex Therapeutics
CLDX
$1.47B
| $15.1M | 1.51% | 558,636 -69,720 | -11% | -$1.88M |
|
16
Viridian Therapeutics
VRDN
$1.5B
| $15M | 1.51% | 1,300,000 | – | – |
|
17
IO Biotech
IOBT
$104M
| $14.1M | 1.41% | 3,015,545 | – | – |
|
|
GTH
18
DELISTED
Genetron Holdings Limited ADS
GTH
| $13.8M | 1.39% | 8,124,174 +712,597 | +10% | +$1.21M |
|
|
19
Ascendis Pharma
ASND
$11.8B
| $13.6M | 1.36% | 146,025 -296,477 | -67% | -$27.6M |
|
20
Legend Biotech
LEGN
$6.41B
| $13.4M | 1.35% | 244,375 | – | – |
|
21
Relmada Therapeutics
RLMD
$37.2M
| $13.4M | 1.35% | 705,882 | – | – |
|
22
Aclaris Therapeutics
ACRS
$209M
| $12.5M | 1.26% | 898,631 | – | – |
|
|
VRNA
23
Verona Pharma
VRNA
$9.16B
| $11.5M | 1.16% | 2,749,918 | – | – |
|
24
Merus
MRUS
$4.98B
| $10M | 1% | 442,000 | – | – |
|
|
25
Zai Lab
ZLAB
$3.68B
| $9.42M | 0.95% | 271,528 +89,951 | +50% | +$3.12M |
|